Ledger.Open graph →
SEC Form D · filed March 10, 2023

Lenz Therapeutics, Inc

Offering
$83.5M
Sold
$83.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DEL MAR, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

James Mccollum · Del Mar, CADirectorZach Scheiner · Del Mar, CADirectorClare Ozawa · Del Mar, CADirectorEvert Schimmelpennink · Del Mar, CAExec · DirectorStefan Larson · New York, NYDirectorFrederic Guerard · Del Mar, CADirectorChris Dimitropoulos · Del Mar, CADirectorTelperion Manager LLC · Bethesda, MDExec · DirectorJeni Stallings · Edmond, OKDirectorDan Santoro · HOUSTON, TXDirectorKen Odom · HOUSTON, TXDirectorLevco Capital Partners LLC · New Fairfield, CTDirectorJames G. Webb · George Town, Grand Cayman, Cayman IslandsExec · DirectorDavid G. Derosa · George Town, Grand Cayman, Cayman IslandsDirectorHenning G. Bruder · George Town, Grand Cayman, Cayman IslandsDirectorStefan Larson · Toronto, Ontario, CanadaDirectorFrederic Guerard · Redwood City, CADirectorChris Dimitropoulos · Del Mar, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗